Skip to main content

Table 5 Effect of RES on HepG2 variant xenograft weight

From: Caveolin-1 enhances resveratrol-mediated cytotoxicity and transport in a hepatocellular carcinoma model

Group

RES

(mg/kg)

n

Tumor

weight/mg

Inhibitory rate %

Intra-group inhibitory rate%

HepG2

0

4

222.50 ± 22.5

  

HepG2

15

4

173.33 ± 33.3a

22.11

22.11

CAV1

0

4

165.50 ± 10.2 a

25.84

 

CAV1

15

4

92.50 ± 15.1b

58.43

44.12

CAVM1

0

4

337.50 ± 20.6 a

-51.68

 

CAVM1

15

4

117.50 ± 12.5 b

47.19

65.19

CAVM2

0

4

170.00 ± 18.9 a

23.61

 

CAVM2

15

4

142.50 ± 15.1 b

35.96

16.17

CAVRNAi

0

2

247.50 ± 7.07 a

-11.21

 

CAVRNAi

15

4

230.00 ± 6.80b

-3.37

7.07

  1. Values are means ± SEM, n = 4.
  2. a. P < 0.05 vs control group.
  3. b. P < 0.05 vs corresponding untreated group (RES at doses of 0 mg/kg)